InsidersTradesSigma
유유제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 유유제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 유유제약 has logged 68 public disclosures. Market capitalisation: €56.1bn. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: 유원상. The full history is openly available.
67
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,273 of 28,134 companies
72.3
score / 100
Value91
Quality54
FCF yld13%
Earn yld14%
EV/EBITDA4.9x
ROE6.8%
Gross mgn38%
Net mgn5.8%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations68 total
Other
Other(filed)
25 of 68 declarations
About 유유제약
유유제약 is a South Korean pharmaceutical company focused on the development and marketing of medications. It is listed on the KRX.